Catherine Van Poznak is an Oncology physician affiliated with University of Michigan. OpenAlex indexes 255 publications with 14,694 citations (h-index 49).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingNIH funding
1 NIH research award on record, funded 2009–2013 per NIH RePORTER. The latest:
- Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Cancer
University of Michigan at Ann Arbor
FY2013$133,920K23DE020197 - Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Cancer
University of Michigan at Ann Arbor
FY2012$133,920K23DE020197 - Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Cancer
University of Michigan at Ann Arbor
FY2011$133,920K23DE020197
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
Eva Feldman, MD
University of Michigan
Matthias Kretzler, MD
University of Michigan
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”